Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Vascul Pharmacol. 2021 Jun 9;139:106881. doi: 10.1016/j.vph.2021.106881

Figure 3.

Figure 3.

Ang-II activates inflammasome in vascular smooth muscle cells via AT1R. Immunoblots of pro-caspase 1 (p40) and active Casp1 (p20) (A) and pro and mature IL-1β (B) and immunoblot representatives (C) in rat aortic vascular smooth muscle cells (RASMC) treated with Ang-II (0,1 μM) for 8 h or 24h with or without losartan (AT1R antagonist, 10μM). N= 4 to 9. Values are reported as mean ± s.e.m. *P<0.05 vs. vehicle; #P<0.05 vs. in presence of losartan.